Tumor volumes were significantly reduced in the OE-TRMT10A group, the sh-tRF-22 group, and the OE-TRMT10A + sh-tRF-22 group compared to the OE-NC + sh-NC group. The gene discussed is TRMT10A; the disease is neoplasm.